We are excited to announce that Health Through Evidence will be participating in the upcoming ISPOR – International Society for Pharmaceutical Outcomes Research – Europe 2024 conference in Barcelona from 17-20 November! Health Through Evidence will be presenting 15...
Happy to share our most recent, open-access publication ”Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece ” in Vaccines (Impact Factor:5.2). Given the significant...
Today, 19 May, we observe World Inflammatory Bowel Disease (IBD) Day, a day dedicated to raising awareness and understanding of this chronic condition that affects millions globally. IBD, which includes Crohn's disease and ulcerative colitis, presents significant...
Health Through Evidence had the pleasure of sponsoring the ‘2nd Educational Conference "Market Access for Non-Market Access." which was held on May 16th in Athens. The themes of the 2nd Educational Conference of ΕΛΕΜΑ / ELEMA - Ελληνική Ένωση Market Access were “the...
Health Through Evidence had the pleasure of sponsoring the '9th Annual HTA Conference' which was held on April 23rd in Athens, organized by BOUSSIAS and Health Daily. The main theme of the 2024 HTA conference was "HTA in a Changing World: Navigating New Challenges...